CTAC is Canada’s national, non-governmental organization led by and for people living with HIV and Viral Hepatitis co-infection, focusing on enabling access to treatment. In operation since 1996, CTAC has recently completed an organizational renewal process to ensure we meet our organizational goals to meaningfully engage community members, service providers, policymakers and other relevant stakeholders to identify, develop and implement policy and program solutions.
CTAC understands that treatment access should be considered in its’ holistic form, encompassing the range of treatment, care and support needs required to reach the most successful treatment experience possible for people living with HIV or those co-infected with Viral Hepatitis.
Treatment Access News
On November 19, the Common Drug Review (CDR) released a request for patient group input on Stribild – a new drug developed by Gilead Sciences that combines four drugs in a once-daily tablet to treat HIV-1 infectionread more